CXCL8 and metastatic malignant neoplasm in the lymph nodes: CXCL8 and its receptor CXCR2 (IL-8 Receptor, beta) are overexpressed in ESCC, and their level correlates with lymphatic invasion, venous invasion, lymph node metastasis, depth of invasion, and poor prognosis [57].